232 related articles for article (PubMed ID: 30400936)
1. Investigate the mechanisms of Chinese medicine Fuzhengkangai towards EGFR mutation-positive lung adenocarcinomas by network pharmacology.
Bing Z; Cheng Z; Shi D; Liu X; Tian J; Yao X; Zhang J; Wang Y; Yang K
BMC Complement Altern Med; 2018 Nov; 18(1):293. PubMed ID: 30400936
[TBL] [Abstract][Full Text] [Related]
2. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
[TBL] [Abstract][Full Text] [Related]
3. Network pharmacology-based and clinically relevant prediction of active ingredients and potential targets of Chinese herbs on stage IV lung adenocarcinoma patients.
Liu J; Hao J; Niu Y; Wu X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):2079-2092. PubMed ID: 33797608
[TBL] [Abstract][Full Text] [Related]
4. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
Li JL; Hou W
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of Fuzheng Kang'ai Formula Regulating Tumor Microenvironment in Non-Small Cell Lung Cancer.
Tian YL; Fu SB; Li B; Yuan LY; Bing ZT
Chin J Integr Med; 2022 May; 28(5):425-433. PubMed ID: 34546538
[TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism of Rhubarb in the treatment of non-small cell lung cancer based on network pharmacology and molecular docking technology.
Tan YR; Lu Y
Mol Divers; 2023 Jun; 27(3):1437-1457. PubMed ID: 35933455
[TBL] [Abstract][Full Text] [Related]
7. FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma.
Tang Q; Xu M; Long S; Yu Y; Ma C; Wang R; Li J; Wang X; Fang F; Han L; Wu W; Wang S
J Ethnopharmacol; 2024 Jan; 318(Pt A):116646. PubMed ID: 37269912
[TBL] [Abstract][Full Text] [Related]
8. MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma.
Yiming R; Takeuchi Y; Nishimura T; Li M; Wang Y; Meguro-Horike M; Kohno T; Horike SI; Nakata A; Gotoh N
Cancer Sci; 2021 Sep; 112(9):3810-3821. PubMed ID: 34145929
[TBL] [Abstract][Full Text] [Related]
9. Network Pharmacology-Based Prediction and Verification of the Active Ingredients and Potential Targets of Zuojinwan for Treating Colorectal Cancer.
Huang S; Zhang Z; Li W; Kong F; Yi P; Huang J; Mao D; Peng W; Zhang S
Drug Des Devel Ther; 2020; 14():2725-2740. PubMed ID: 32764874
[TBL] [Abstract][Full Text] [Related]
10. Reduction in gefitinib resistance mediated by Yi-Fei San-Jie pill in non-small cell lung cancer through regulation of tyrosine metabolism, cell cycle, and the MET/EGFR signaling pathway.
Yang CZ; Guo W; Wang YF; Hu LH; Wang J; Luo JM; Yao XH; Liu S; Tao LT; Sun LL; Lin LZ
J Ethnopharmacol; 2023 Oct; 314():116566. PubMed ID: 37169317
[TBL] [Abstract][Full Text] [Related]
11. Using Network Pharmacology and Molecular Docking to Explore the Mechanism of Shan Ci Gu (
Wang Y; Zhang Y; Wang Y; Shu X; Lu C; Shao S; Liu X; Yang C; Luo J; Du Q
Front Chem; 2021; 9():682862. PubMed ID: 34178945
[No Abstract] [Full Text] [Related]
12. A network pharmacology-based investigation on the bioactive ingredients and molecular mechanisms of Gelsemium elegans Benth against colorectal cancer.
Que W; Chen M; Yang L; Zhang B; Zhao Z; Liu M; Cheng Y; Qiu H
BMC Complement Med Ther; 2021 Mar; 21(1):99. PubMed ID: 33743701
[TBL] [Abstract][Full Text] [Related]
13. The Efficacy of Traditional Chinese Herbal Medicine in the Treatment of EGFR Mutated Stage IV Pulmonary Adenocarcinoma Patients Who Received First-Line EGFR-TKI Treatment.
Hung HY; Tseng YH; Liao CM; Chen SY; Wu TP; Lee YC; Chen YM
Integr Cancer Ther; 2017 Mar; 16(1):126-131. PubMed ID: 27151582
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of the Bushen Huoxue formula in the treatment of osteoarthritis based on network pharmacology-molecular targets.
Pang T; Liu C; Yao J; Li J; Li Z; Lou H; Lei S; Zhang J; Dong L; Wang Y
Medicine (Baltimore); 2022 Aug; 101(32):e29345. PubMed ID: 35960090
[TBL] [Abstract][Full Text] [Related]
15. Molecular targets and mechanisms of Guanxinning tablet in treating atherosclerosis: Network pharmacology and molecular docking analysis.
Niu C; Zhang P; Zhang L; Lin D; Lai H; Xiao D; Liu Y; Zhuang R; Li M; Ma L; Ye J; Pan Y
Medicine (Baltimore); 2023 Sep; 102(39):e35106. PubMed ID: 37773840
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of Bai He Gu Jin Tang against non-small cell lung cancer revealed by network pharmacology and molecular docking.
Xie RF; Song ZY; Xu-Shao LY; Huang JG; Zhao T; Yang Z
Medicine (Baltimore); 2022 Dec; 101(52):e32555. PubMed ID: 36596057
[TBL] [Abstract][Full Text] [Related]
17. The repression and reciprocal interaction of DNA methyltransferase 1 and specificity protein 1 contributes to the inhibition of MET expression by the combination of Chinese herbal medicine FZKA decoction and erlotinib.
Zheng F; Zhao Y; Li X; Tang Q; Wu J; Wu W; Hann SS
J Ethnopharmacol; 2019 Jul; 239():111928. PubMed ID: 31077779
[TBL] [Abstract][Full Text] [Related]
18. Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of BanXia-YiYiRen in treating insomnia.
Wang L; Wang P; Chen Y; Li C; Wang X; Zhang Y; Li S; Yang M
Bioengineered; 2022 Feb; 13(2):3148-3170. PubMed ID: 35067174
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Key Ingredient of Astragalus membranaceus on Lung Adenocarcinoma via PI3K/AKT Signaling Clarified by Utilizing Network Pharmacology Approach and Experimental Validation.
Wang YC; Hui JR; Xiao G; Ma QL
Chin J Integr Med; 2023 Mar; 29(3):244-252. PubMed ID: 36044117
[TBL] [Abstract][Full Text] [Related]
20. Licochalcone B inhibits growth and induces apoptosis of human non-small-cell lung cancer cells by dual targeting of EGFR and MET.
Oh HN; Lee MH; Kim E; Yoon G; Chae JI; Shim JH
Phytomedicine; 2019 Oct; 63():153014. PubMed ID: 31323446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
